As a part of its corporate strengthening initiatives Biological E has appointed new top management personnel to expand its management team.

Mr.Suresh Mundra has joined the company in the capacity of Chief Operating Officer and will lead Process Operations, Supply Chain Management, Finance and other operations of the company. Mr. Suresh Mundra brings with him rich experience.

Mr. Rayasam Prasad has joined the Biological E Limited as Chief Operating Officer for Global Biologics. Mr. Prasad will be responsible for Technical Operations, Production, Process Development and Quality Management for Vaccines and Biopharmaceuticals.

Mr. Rayasam Prasad till recently served as a Senior Vice President at Reliance Life Sciences for an year, was responsible for Global Quality Management and Regulatory Compliance. Prior to Reliance, Mr. Prasad spent more than 25 years in USA and Europe in leadership and management roles at Genentech, Chiron Vaccines, Medimmune and Genzyme.

As a part of its corporate strengthening initiatives Biological E has appointed new top management personnel to expand its management team.

Mr.Suresh Mundra has joined the company in the capacity of Chief Operating Officer and will lead Process Operations, Supply Chain Management, Finance and other operations of the company. Mr. Suresh Mundra brings with him rich experience.

Mr. Rayasam Prasad has joined the Biological E Limited as Chief Operating Officer for Global Biologics. Mr. Prasad will be responsible for Technical Operations, Production, Process Development and Quality Management for Vaccines and Biopharmaceuticals.

Mr. Rayasam Prasad till recently served as a Senior Vice President at Reliance Life Sciences for an year, was responsible for Global Quality Management and Regulatory Compliance. Prior to Reliance, Mr. Prasad spent more than 25 years in USA and Europe in leadership and management roles at Genentech, Chiron Vaccines, Medimmune and Genzyme.

- End -

Established in 1953, Biological E. Ltd. (BE) has been a leading vaccine and pharmaceutical company based out of Hyderabad, India. The company produces a range of critical vaccines and has been an active partner with the National Immunization Programs of various countries. The company continues to invest in large-scale cGMP facilities in order to increase its capacities and product range to offer vaccines/biologics on a global basis including US FDA and EMEA markets. In addition to its pipeline of vaccines and biologics, the company has entered into a number of strategic collaborations with leading biotech companies and research institutes for joint R&D projects. Biological E. is a privately held company and is run by professionals with significant experience in the global biopharmaceutical business.

For more information, please visit the company’s website at http://www.biologicale.com